News

Veeva Unveils Innovative Cloud CTMS for Research Sites

Veeva Unveils Innovative Cloud CTMS for Research Sites

Veeva Launches the Future of Clinical Trial Management

Veeva Systems (NYSE: VEEV) is excited to unveil its latest innovation, the Veeva SiteVault CTMS, designed specifically for research sites. This advanced clinical trial management system is engineered to enhance efficiency and seamlessly integrate with clinical trial sponsors, revolutionizing the way research teams operate.

Enhanced Efficiency with Veeva SiteVault CTMS

The Veeva SiteVault CTMS offers an all-in-one interface that allows research sites to manage clinical trials effectively. By integrating Veeva's existing technologies, such as SiteVault eISF and SiteVault eConsent, this system simplifies the management process. It enables research teams to engage in a smooth data flow with sponsors, significantly reducing manual work and improving overall operational efficiency.

Supporting Families in Clinical Research

Theresa Oswald, a leading research operations director, emphasizes the importance of efficiency in clinical studies, stating, "We need to work efficiently to help more families enroll their children in studies and get lifesaving treatment." The Veeva SiteVault CTMS aims to streamline user experiences, ultimately benefiting the patients relying on these trials.

A Commitment to Efficiency

Nick Frenzer, general manager of site solutions at Veeva, expressed enthusiasm for the release of Veeva SiteVault CTMS, saying, "High-quality cloud software and seamless sponsor integration will help sites be more efficient." Veeva is committed to making this platform available for free to more than 90% of research sites, reflecting its dedication as a Public Benefit Corporation to enhancing clinical research for both sites and sponsors.

Getting Started with Veeva SiteVault CTMS

While the initial rollout of Veeva SiteVault CTMS is slated for late 2025, it will be freely accessible for sites conducting up to 20 concurrent active studies. This initiative not only lowers barriers to entry for research teams but also signifies Veeva's commitment to making impactful tools available to those who need them most.

Live Demos at ACRP 2025

Interested parties are invited to learn more about Veeva SiteVault CTMS and view live demonstrations at the ACRP 2025 event taking place in New Orleans. This gathering will present an excellent opportunity for research professionals to see firsthand how Veeva's clinical trial management system can enhance their capabilities.

Additional Insights About Veeva Systems

Veeva Systems is recognized globally as a leader in cloud software for the life sciences sector. The company prides itself on innovation, product excellence, and prioritizing customer success. With an impressive customer base consisting of over 1,000 companies, Veeva caters to a range of clients from major biopharmaceutical corporations to emerging biotech firms.

Being a Public Benefit Corporation, Veeva is dedicated to upholding a balance among the interests of its customers, employees, stakeholders, and the broader industry. This commitment enhances the quality of services provided, ensuring they meet the evolving needs of their clientele.

Frequently Asked Questions

What is Veeva SiteVault CTMS?

Veeva SiteVault CTMS is a cloud-based clinical trial management system created to enhance efficiency at research sites.

Who can benefit from the Veeva SiteVault CTMS?

Research sites conducting clinical trials will benefit significantly from the streamlined management and data integration provided by Veeva SiteVault CTMS.

When will Veeva SiteVault CTMS be available?

The system is planned for an initial release in late 2025, with free access for sites conducting up to 20 concurrent studies.

Where can I learn more about Veeva's offerings?

For further information about Veeva Systems and its solutions, visit the official Veeva website.

Will Veeva SiteVault CTMS charge fees for usage?

Veeva has committed to providing this system for free to over 90% of research sites, promoting accessibility in clinical research.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Striveworks: Boosting Army's AI Edge in Indo-Pacific

Updated Category News Views 6

The world keeps marching forward, and here’s Striveworks stepping up to the plate with another big move in the military tech space. This isn't your average partnership renewal; this involves a five-year, $200 million deal to enhance battlefield AI as the U.S. Army hones its modern warfare edge in the Indo-Pacific. Now, this isn't just a battle of strategies but a battle...

Continue Reading
Teamsters Secure Landmark Deal for SF Parking Workers

Updated Category News Views 4

Major Win for San Francisco's Parking Professionals Parking lots and garages across San Francisco might not be the first places you’d look for labor triumphs, but that’s exactly what almost 1,000 members of Teamsters Local 665 have achieved. Under a newly ratified four-year master contract, these parking pros snagged one of the richest deals the industry has seen. A...

Continue Reading
Lupin Secures FDA Nod for Key Injectable Drug

Updated Category News Views 4

Lupin's FDA Approval: A Strategic Play in Pharmaceuticals Ah, the thrill of a new approval! Lupin Limited has landed U.S. FDA approval for their Phytonadione Injectable Emulsion, marking a significant stride into the lucrative realm of vitamin K treatments. This approval isn't just a feather in Lupin's cap—it's a calculated move to corner a piece of the estimated $52.3...

Continue Reading
Webull Faces Legal Scrutiny Over Chinese Ties

Updated Category News Views 5

The Unfolding Drama for Webull Shareholders When you see a ticker like NASDAQ:BULL rolling off your tongue these days, it’s not just about stock prices anymore—it's a whole saga wrapped in legal and geopolitical spice. Following the recent uproar from a House China committee report, Webull found itself thrust into the spotlight for all the wrong reasons. That report...

Continue Reading
Hexaware Teams with Anthropic for Game-Changing AI Move

Updated Category News Views 4

A Bold AI Partnership on the Horizon Mutual back-slapping or a deal with authentic grit? Hexaware’s latest tango with Anthropic might just be the jolt enterprises need. Announced under the flickering fluorescent lights of Mumbai, London, and Iselin, Hexaware’s multi-year partnership with Anthropic thrusts Claude, their razor-sharp AI, right into the mix of...

Continue Reading
Mexico's Beaches Shine in 2026 Best America Rankings

Updated Category News Views 5

Mexican Shores Turning Heads in 2026 This isn’t just another wave in tourism news; it’s a tidal shift towards Mexico’s sizzling beaches claiming some prime spots on the global travel stage. If you’ve got an eye for tourism dynamics, listen up because Mexico’s sun-soaked shores just snagged six spots among the top 20 beaches in the Americas, according to the...

Continue Reading
Rutter Mills Secures $13M in Virginia Injury Cases

Updated Category News Views 4

The Stakes in Virginia When you drop nine successful injury cases on the scales and they tip over $13 million, that's a story worth dissecting. The two top dogs at Rutter Mills certainly know how to make a splash in the legal puddle, don't they? We're talking about attorneys Adam H. Lotkin and Georgina D. Montgomery here, the legal eagles behind these jaw-dropping...

Continue Reading
Ajman Tourism Department Hits Internal Audit Milestone

Updated Category News Views 4

A Nod to Standards in Ajman's Tourism Department Folks, it's not every day you see a government department get this kind of spotlight in the internal audit arena, yet here we are. The Ajman Department of Tourism, Culture and Media has snagged Full Conformance with Internal Audit Quality Standards. That’s not just some random feather in their cap but a signal flare in...

Continue Reading
Raken Debuts Change Orders: A Game-Changer for Builds

Updated Category News Views 4

Construction Gets a Streamlined Boost with Raken's New Tool In construction, chaos often partners seamlessly with progress. But Raken is stepping in to shake things up a bit. This isn’t just another run-of-the-mill software update; this is Raken flexing its muscles in the construction tech arena. They’ve rolled out Change Orders, enhancing their project management...

Continue Reading
Full Sail University Bags Billboard Music School Honor

Updated Category News Views 6

Full Sail Scores a Billboard Nod — What's the Big Deal? Alright, Full Sail University just snagged a spot on Billboard Magazine's 2026 Top Music Business Schools list. That's no small fry, folks. This Florida institution has been carving out a niche in the music business education scene with a hands-on learning approach that hits the nail right on the head. The Recipe...

Continue Reading

Top 5 Most Recently Viewed Articles

Navigating Tech Stock Dips: Smart Investment Choices Ahead

Updated Category News Views 91

Understanding Tech Stock Volatility Investors are well aware that tech stocks can yield mixed results in their portfolios. The rapidly changing technology landscape means that companies can swiftly shift from promising to problematic. While hype-fueled rallies can lead to substantial short-term gains, they can also set the stage for severe corrections. Recently, three...

Continue Reading
Revolutionizing Manufacturing: Solumina Intelligence Unveiled

Updated Category News Views 221

Solumina Intelligence: Transforming Manufacturing Analytics Unlocking real-time shop floor data for faster, smarter decision-making iBase-t, a frontrunner in cloud software for the Aerospace and Defense sector, has introduced Solumina Intelligence. This AI-driven data intelligence tool is a game-changer for the Solumina Manufacturing Operations Platform. Utilizing the...

Continue Reading
Fostering Future Dental Professionals to Meet Community Needs

Updated Category News Views 287

Empowering the Next Generation of Oral Health Professionals As the nation faces a growing shortage of oral health professionals, organizations like Planet Smilez are pioneering efforts to cultivate future providers. This initiative emphasizes the importance of early exposure to the field, hands-on learning experiences, and mentorship tailored for students from...

Continue Reading
Empowering Women in Mining: Canada Nickel's New Commitment

Updated Category News Views 149

Canada Nickel Joins Equal by 30 Campaign Canada Nickel Company Inc. (TSXV: CNC) (OTCQX: CNIKF) is thrilled to announce its involvement in the Equal by 30 campaign, a vital initiative designed to enhance career opportunities for women within the mining sector. This commitment aims to foster an equitable environment in the Canadian mining industry as we approach the next...

Continue Reading
Plus Therapeutics Unveils Promising CNSide Results for Cancer Care

Updated Category News Views 126

Exciting Developments from Plus Therapeutics Plus Therapeutics, Inc. (NASDAQ: PSTV), a key player in the clinical-stage pharmaceutical realm, has recently shared encouraging data from their CNSide CSF Assay Platform. This significant announcement was made during the Society for Neuro-Oncology (SNO) and American Society of Clinical Oncology (ASCO) conference, focusing on...

Continue Reading